SCHEMBL2065282

SCHEMBL2065282

C=CC(=O)OCC(C)OC(=O)CCC(=O)O

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 8/20 0.58
HPGD P15428 1/20 0.36
ALDH1A1 P00352 4/20 0.35
TP53 P04637 3/20 0.35
HIF1A Q16665 3/20 0.35
CYP3A4 P08684 2/20 0.35
HSD17B10 Q99714 1/20 0.35
KDM6B O15054 1/20 0.34
KDM5C P41229 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
PHF8 Q9UPP1 1/20 0.34
KDM2A Q9Y2K7 1/20 0.34
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
THRB P10828 2/20 0.31
SLC6A2 P23975 1/20 0.30
SLC6A4 P31645 1/20 0.30
BLM P54132 1/20 0.30
SLC6A3 Q01959 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17696343 0.87 TSHR (0.58) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL1071857 0.87 TSHR (0.49) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL19845081 0.87 TSHR (0.49) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL19845084 0.87 TSHR (0.49) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL27993897 0.86 TSHR (0.47) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL19064328 0.86 TSHR (0.56) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL19845005 0.84 TSHR (0.42) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL17693828 0.83 TSHR (0.53) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL11679497 0.83 EGLN1 (0.41) TSHRALDH1A1KDM6BKDM5CEGLN1
SCHEMBL17506142 0.83 EGLN1 (0.41) TSHRALDH1A1KDM6BKDM5CEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873426-B2 Curable composition, cured product, optical member, lens, and compound FUJIFILM CORPORATION (JP) 2024-01-16 US disclosed
US-20230280500-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC CURABLE COMPOSITION, CURED BODY, LENS AND EYEGLASSES TOKUYAMA CORPORATION (JP) 2023-09-07 US disclosed
EP-3152267-B1 ENERGY CURABLE PRINTING INKS AND COATING COMPOSITIONS CONTAINING METHL PHENYL GLYCOXYLATE SUN CHEMICAL CORP (US) 2021-04-21 EP disclosed
US-20180037819-A1 OPTICAL ISOMER SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) 2018-02-08 US disclosed
US-20170198156-A1 ENERGY CURABLE PRINTING INKS AND COATING COMPOSITIONS CONTAINING METHYL PHENYL GLYCOXYLATE SUN CHEMICAL CORPORATION (US) 2017-07-13 US disclosed
US-20170174991-A1 POLYMERIZABLE COMPOUND, POLYMER, POLYMERIZABLE COMPOSITION, AND FILM FUJIFILM CORPORATION (JP) 2017-06-22 US disclosed
US-20170174991-A1 POLYMERIZABLE COMPOUND, POLYMER, POLYMERIZABLE COMPOSITION, AND FILM FUJIFILM CORPORATION (JP) 2017-06-22 US disclosed
EP-3152267-A1 ENERGY CURABLE PRINTING INKS AND COATING COMPOSITIONS CONTAINING METHL PHENYL GLYCOXYLATE Sun Chemical Corporation (US) 2017-04-12 EP disclosed
US-20160108315-A1 OPTICALLY ANISOTROPIC LAYER, METHOD FOR PRODUCING THE OPTICALLY ANISOTROPIC LAYER, A LAMINATE, POLARIZING PLATE, DISPLAY DEVICE, LIQUID CRYSTAL COMPOUND, METHOD FOR PRODUCING THE LIQUID CRYSTAL COMPOUND, AND CARBOXYLIC ACID COMPOUND FUJIFILM CORPORATION (JP) 2016-04-21 US disclosed
US-20160108315-A1 OPTICALLY ANISOTROPIC LAYER, METHOD FOR PRODUCING THE OPTICALLY ANISOTROPIC LAYER, A LAMINATE, POLARIZING PLATE, DISPLAY DEVICE, LIQUID CRYSTAL COMPOUND, METHOD FOR PRODUCING THE LIQUID CRYSTAL COMPOUND, AND CARBOXYLIC ACID COMPOUND FUJIFILM CORPORATION (JP) 2016-04-21 US disclosed
WO-2015191440-A1 ENERGY CURABLE PRINTING INKS AND COATING COMPOSITIONS CONTAINING METHL PHENYL GLYCOXYLATE SUN CHEMICAL CORPORATION (US) 2015-12-17 WO disclosed
US-8148461-B2 crosslinked latex-based inks, coatings and/or paints having improved color and water durability, for use in ink-jet printing; colorfastness HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2012-04-03 US disclosed
EP-1431339-B1 Ink composition comprising latex particulate compositions HEWLETT PACKARD DEVELOPMENT CO (US) 2010-02-24 EP disclosed
US-7358301-B2 Latex particles having incorporated image stabilizers HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2008-04-15 US disclosed
US-20080070038-A1 Latex particles having incorporated image stabilizers VINCENT KENT 2008-03-20 US disclosed
EP-1431339-A1 Latex particulate composition Hewlett-Packard Development Company, L.P. (US) 2004-06-23 EP disclosed
US-20040116596-A1 Latex particles having incorporated image stabilizers HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2004-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174991-A1 POLYMERIZABLE COMPOUND, POLYMER, POLYMERIZABLE COMPOSITION, AND FILM SP1, PYM1, H1-0 TSHR 4102/4885HPGD 4265/4885ALDH1A1 3739/4885
US-11873426-B2 Curable composition, cured product, optical member, lens, and compound RB1, CCNO, SPOP TSHR 3973/4885HPGD 2404/4885ALDH1A1 2783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.